Synmosa Biopharma Corporation (TPEX:4114)

Taiwan · Delayed Price · Currency is TWD

29.55

+0.25 (0.85%)

Sep 30, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Intersegment Income	-276.90M	-210.22M	-146.19M	-86.89M	-31.13M
Pharmaceutical Ingredients Department	467.25M	363.24M	325.78M	234.87M	119.57M
New Drugs Segment	6.00B	5.40B	4.96B	4.24B	3.15B
Total	6.19B	5.55B	5.14B	4.39B	3.23B

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	5.24B	4.76B	4.45B	3.88B	2.81B
China	698.28M	564.55M	450.98M	271.73M	293.58M
United States	25.60M	2.21M	28.78M	62.74M	8.66M
Canada	11.15M	2.14M	15.50M	34.97M	30.29M
Thailand	45.81M	29.70M	54.56M	39.60M	23.16M
Malaysia	28.43M	34.36M	36.45M	30.75M	19.41M
Singapore	80.00M	75.89M	41.91M	-	-
Other	61.76M	79.11M	60.80M	70.10M	46.47M
Total	6.19B	5.55B	5.14B	4.39B	3.23B